1 patient evaluation for ALS Phase 2 Study Lithium Carbonate

Jul 20, 2011 (Started Jan 19, 2010)

  • Effectiveness
    Can't tell (for Participate in clinical trial)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 885 mcg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

  • 1 helpful mark
Last updated:
Showing 1 of 1 patient evaluation for ALS Phase 2 Study Lithium Carbonate